RMTG (Regenerative Medical Technology Group) Valuation Rank

View and export this data going back to . Start your Free Trial

What is Regenerative Medical Technology Group Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

Three factors:
- Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
- Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
- Industry relative valuation
Companies without enough data is not ranked
Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Regenerative Medical Technology Group Valuation Rank Related Terms

Thank you for viewing the detailed overview of Regenerative Medical Technology Group's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Regenerative Medical Technology Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Regenerative Medical Technology Group Inc (OTCPK:RMTG) » Definitions » Valuation Rank

Comparable Companies

Traded in Other Exchanges

N/A

Address

433 Plaza Real, Suite 275, Boca Raton, FL, USA, 33432

Website

https://www.regenmedtechgroup.com

Regenerative Medical Technology Group Inc operates through its subsidiary. Its focus has been mainly dedicated to its operations serving the markets in the regenerative medicine industry. It believes stem cell therapy is becoming an increasingly effective clinical solution for treating conditions that traditional or conventional medicine only offers within palliative care and pain management. Patients around the world are seeking a natural regenerative alternative without the potential risks and side effects sometimes associated with conventional pharmaceuticals.

Executives

Benito Novas	10 percent owner	433 PLAZA REAL, SUITE 275, BOCA RATON FL 33432
David Eugene Christensen	director, 10 percent owner, officer: President and CEO	433 PLAZA REAL, SUITE 275, BOCA RATON FL 33432
Pereira Melvin Antonio Loria	director, 10 percent owner, officer: CEO, Chairman	RESIDENCIAL HACIENDA EL GREGAL, #24-1 SANCHEZ, CURRIDABAT, SAN JOSE G2 11803